A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Pegfilgrastim
Related studies linked through entity extraction aliases.
LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
- Status
- COMPLETED
- Phase
- PHASE2
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
- Status
- COMPLETED
- Phase
- PHASE2
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
KRN125 for Mobilization of Hematopoietic Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
Split-Dose R-CHOP for Older Adults With DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1